-
AstraZeneca Ordered to Pay Pfizer's Wyeth $107.5 Million in Patent Infringement Case over Cancer Dru...
In a landmark decision, a federal jury in Delaware has ruled that AstraZeneca must pay Pfizer's Wyeth division a staggering $107.5 million in damages ...
2024-05-23 15:34 -
Top 10 Highest Revenue Growth Rates Among Pharma Giants in 2024 Q1
In the first quarter of 2024, the global biopharmaceutical industry witnessed remarkable growth, with 18 out of the top 25 pharmaceutical companies re...
2024-05-23 15:31 -
AstraZeneca's Ambitious $80 Billion Revenue Target for the Next Decade
In the next 10 years, AstraZeneca aims to achieve an ambitious $80 billion in annual revenue, nearly doubling its 2023 figure of $45.8 billion.
2024-05-23 15:30 -
Domestic Innovation Drugs Stage a Comeback: China's Rise in ASCO 2024
The medical industry has been facing a challenging period, but domestic Chinese pharmaceutical companies have found a way to turn the tide.
2024-05-20 16:32 -
Johnson & Johnson's Strategic Acquisition Bolsters its Immunology Pipeline
Johnson & Johnson has made another strategic move in the pharmaceutical industry by acquiring Proteologix, a biopharmaceutical company focused on deve...
2024-05-20 16:31 -
Mapping Hengrun's GLP-1 Global Expansion: A $6 Billion Journey
In a landmark move, China's pharmaceutical giant Hengrun has licensed out the global development, manufacturing and commercialization rights (excludin...
2024-05-20 16:30 -
The Changing of the Guard: China's Pharmaceutical Landscape Evolves
As the country's "Pharmaceutical King," Hengrui Medicine, approaches a generational change, a new contender is poised to take the throne – Beigene....
2024-05-20 16:29 -
Hefty $6 Billion Deal: Hengrui Licenses GLP-1 Portfolio to Hercules
Hengrui Medicine, a leading innovative global pharmaceutical company, has announced a landmark deal.
2024-05-20 16:29 -
The Milestone in the Journey of Domestic Weight Loss Drugs: Hengrui's Breakthrough!
This article explores the progress made by these domestic pharmaceutical companies and the key factors that will determine their success in this fierc...
2024-05-11 15:07 -
GSK China Experiences Leadership Transition: A New Era Begins
In a significant development for GSK China, the pharmaceutical giant has undergone a leadership transition, marking the start of a new era.
2024-05-11 15:06
Hot News
- BASF’s Big Restructuring: Cut... Sep 01, 2025
- German Chemical Industry Outpu... Sep 15, 2025
- DuPont Bids Farewell to Its Ar... Sep 02, 2025
- ExxonMobil Eyes $1 Billion Pet... Sep 16, 2025
- FDA Clears Sanofi’s Wayrilz (... Aug 31, 2025
Related Products
Related Producers
